Andere talen Positive Group

Aandelen

POSI

RU000A103X66

slotkoers Moscow Micex - RTS Andere beurzen 00:00:00 08-07-2022			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
869,6 ^RUB	+0,65%		-.--%	-.--%

26/04	De Publieke Joint Stock Company Positive Group rapporteert winstresultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
10/04	De Publieke Joint Stock Company Positive Group rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Public Joint Stock Company Positive Group Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Public Joint Stock Company Positive Group Reports Earnings Results for the Full Year Ended December 31, 2023	10/04
Public Joint Stock Company Positive Group Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Public Joint Stock Company Positive Group Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	26-07-23
Public Joint Stock Company Positive Group Reports Earnings Results for the First Quarter Ended March 31, 2023	30-04-23
Public Joint Stock Company Positive Group Reports Earnings Results for the Full Year Ended December 31, 2022	04-04-23
Certain Ordinary Shares of Public Joint Stock Company Positive Group are subject to a Lock-Up Agreement Ending on 29-MAR-2023.	29-03-23
Draftkings Positive Group Dynamics Supports Long-term Margin Targets if More States Legalize Gambling, Oppenheimer Says	11-04-22
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Treatment for Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma	04-11-21
Innovent Biologics, Inc. Announces National Medical Products Administration of China Accepts the Supplemental New Drug Application	04-11-21
Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma	16-08-21
Stoxx Europe 600 : European Stocks End Lower Ahead of US Fed Minutes	19-05-21
Porsche Automobil : Q1 Profit Grows Tenfold On Volkswagen Investment	19-05-21
Bastei Lübbe AG Announces Earnings Guidance for the Year 2020	12-11-20
Gesco AG Revises Earnings Guidance for the Year 2020	03-08-20
Viela Bio Announces U.S. FDA Approval of Uplizna (Inebilizumab-Cdon) for the Treatment of Neuromyelitis Optica Spectrum Disorder	11-06-20
Corvus Pharmaceuticals, Inc. Announces Updated Results from Its Phase 1B/2 Clinical Trial of Ciforadenant	29-05-20
Hansa Biopharma Announces Long Term Follow-Up Data That Demonstrates 2-Year Graft Survival of 89% After Imlifdase Treatment and Transplantation	06-03-20
Corvus Pharmaceuticals, Inc. Presents Updated Data from CPI-006 Phase 1/1b Clinical Trial at 2019 Society for Immunotherapy of Cancer Annual Meeting	08-11-19
Resimac Group Ltd acquired 15% stake in Positive Group Australia Pty Ltd for AUD 3 million.	03-07-19

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Positive Group

Aandelen

POSI

RU000A103X66

Andere talen

Filters